immunotherapy
Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.
Three promising bacteria were linked to better treatment responses in melanoma patients.
Dietary intervention and the utilization of D. dubosii offer potential insights for the treatment of brain tumor patients.
Preclinical findings will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.
Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment.
The presence of specific microbes in the gut microbiota can serve as biomarkers for predicting the efficacy of immunotherapy.
Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.
The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.
Microbiomepost discussed with Lisa Derosa, oncologist at Gustave Roussy Hospital in Paris, about the link between gut dysbiosis and cancer, shedding light on its role in immunotherapy resistance and patient…
The balance of specific microbes in the gut can help predict who will respond to immunotherapy drugs.
